ASX:ADO AnteoTech (ADO) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ADO Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.43 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield5.08%Price TargetN/A Stock AnalysisStock Analysis Get AnteoTech alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About AnteoTech Stock (ASX:ADO)AnteoTech Limited develops, commercializes, manufactures, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. Its products include AnteoBind ready-to-use applications to streamline and enhance the conjugation process; and AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> ADO Stock News HeadlinesFebruary 29, 2024 | finance.yahoo.comWe're Keeping An Eye On AnteoTech's (ASX:ADO) Cash Burn RateNovember 23, 2023 | au.investing.comIondrive progressing battery recycling technologies towards commercialisationApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.November 1, 2023 | msn.comASX Biotech October Winners: Dimerix, Noxopharm and Chimeric dominate as investors hunt next big thing in pharmaSeptember 21, 2023 | proactiveinvestors.com.auAnteoTech with Proactive at ASX Small and Mid Cap ConferenceAugust 3, 2023 | ft.com‘Freedom conservatism’ is much ado about nothingApril 4, 2023 | finance.yahoo.comInvesting in AnteoTech (ASX:ADO) five years ago would have delivered you a 199% gainFebruary 22, 2023 | finance.yahoo.comAnteoTech First Half 2023 Earnings: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)April 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 18, 2023 | mirror.co.ukMillionaire sprinter A Case Of You leaves Ado McGuinness to continue career in AustraliaNovember 27, 2022 | bbc.co.ukMuch Ado About Nothing - Plot summaryOctober 24, 2022 | finance.yahoo.comWe Think AnteoTech (ASX:ADO) Needs To Drive Business Growth CarefullyAugust 14, 2022 | reuters.comADO.AX - Anteotech Ltd | Stock Price & Latest News | ReutersAugust 3, 2022 | finance.yahoo.comThose who invested in AnteoTech (ASX:ADO) three years ago are up 450%July 16, 2022 | barrons.comAnteoTech Ltd.July 10, 2022 | fool.com.auAnteotech share price surges 20% after passing first lithium battery hurdleMay 18, 2022 | fool.com.auWhy the AnteoTech share price is rocketing 33% todayMay 2, 2022 | finance.yahoo.comWe Think AnteoTech (ASX:ADO) Can Afford To Drive Business GrowthApril 9, 2022 | uk.investing.comAnteo Diagnostics Ltd (ADO)March 30, 2022 | au.finance.yahoo.comAnteoTech Limited (ADO.AX)March 22, 2022 | msn.comHere’s why the Anteotech (ASX:ADO) share price is leaping 6% todayFebruary 24, 2022 | finance.yahoo.comWhile AnteoTech (ASX:ADO) shareholders have made 961% in 3 years, increasing losses might now be front of mind as stock sheds 17% this weekFebruary 10, 2022 | msn.comThe AnteoTech (ASX:ADO) share price RAT-tles down 8% following TGA updateFebruary 8, 2022 | msn.comRats! How have AnteoTech (ASX:ADO) shares already gained 30% in February?February 1, 2022 | msn.comAnteoTech (ASX:AD) share price surges 15% as COVID-19 RAT race continuesJanuary 31, 2022 | msn.comWhy did the AnteoTech (ASX:ADO) share price tumble 13% on MondayJanuary 28, 2022 | fool.com.auWhy the AnteoTech (ASX:ADO) share price is plummeting 23% on FridaySee More Headlines Receive ADO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AnteoTech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2019Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:ADO CUSIPN/A CIKN/A Webwww.anteodx.com Phone61 7 3219 0085FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,460,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-168.00% Return on Assets-58.59% Debt Debt-to-Equity Ratio20.90 Current Ratio2.90 Quick Ratio6.54 Sales & Book Value Annual Sales$1.02 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow22.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,200,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.25 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. David John Radford B.Sc.BSc (Hons), M.B.A., MAICD, MD, CEO & Executive DirectorDr. N. Joe Maeji B.Sc.Ph.D., Founder & Chief Scientific OfficerMr. Andrew CookCFO & Company SecretaryMs. Katrina ByrneChief Operating OfficerMs. Tsui Min LianChief Marketing OfficerMr. Selahattin GulduExecutive Vice President of Commercial BankingMr. Manuel WieserHead of EnergyMr. Pierre NathieHead of Products & Services Life SciencesMr. Ian SteinhardtHead of Market Operations Life SciencesMs. Friederike GraserDirector of Strategic Growth InitiativesMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersGeoffrey CummingSold 1,500,000 sharesTotal: $51,000.00 ($0.03/share)Ewen CrouchSold 468,750 sharesTotal: $12,656.25 ($0.03/share)Geoffrey CummingBought 937,500 shares on 9/11/2023Total: $30,000.00 ($0.03/share) ADO Stock Analysis - Frequently Asked Questions How were AnteoTech's earnings last quarter? AnteoTech Limited (ASX:ADO) issued its earnings results on Wednesday, February, 27th. The company reported $0.00 EPS for the quarter. What other stocks do shareholders of AnteoTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other AnteoTech investors own include Mesoblast (MSB) and Evolution Mining (EVN). This page (ASX:ADO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnteoTech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
